Your account is not claimed yet. You can sign up with ORCID to claim your account.

Nathalie Meurice

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 2

Top Topics

Cell Cycle Arrest

Acute Lymphoblastic Leukemia

Signaling Pathway

Multiple Myeloma

Top Venues

Molecular cancer therapeutics

Blood cancer discovery

Mayo Clinic

PCI Group, University of Namur (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Mayo Clinic Jan 19o 2017

United States

Research Scientist :: Department of Hematology / Oncology

Education History

PCI Group, University of Namur

Belgium

PHD

Publications

Seth J Welsh, Benjamin G Barwick, Erin W Meermeier, Daniel L Riggs, Chang-Xin Shi, Yuan Xiao Zhu, Meaghen E Sharik, Megan T Du, Leslie D Abrego Rocha, Victoria M Garbitt, Caleb K Stein, Joachim L Petit, Nathalie Meurice, Yuliza Tafoya Alvarado, Rodrigo Fonseca, Kennedi T Todd, Sochilt Brown, Zachary J Hammond, Nicklus H Cuc, Courtney Wittenberg, Camille Herzog, Anna V Roschke, Yulia N Demchenko, Wei-Dong D Chen, Peng Li, Wei Liao, Warren J Leonard, Sagar Lonial, Nizar J Bahlis, Paola Neri, Lawrence H Boise, Marta Chesi, Peter Leif Bergsagel
Transcriptional heterogeneity overcomes super-enhancer disrupting drug combinations in multiple myeloma. Blood cancer discovery (2023)
Amber L Fifield, Paul D Hanavan, Douglas O Faigel, Eduard Sergienko, Andrey Bobkov, Nathalie Meurice, Joachim L Petit, Alysia Polito, Thomas R Caulfield, Erik P Castle, John A Copland, Debabrata Mukhopadhyay, Krishnendu Pal, Shamit K Dutta, Huijun Luo, Thai H Ho, Douglas F Lake
Molecular Inhibitor of QSOX1 Suppresses Tumor Growth In Vivo. Molecular cancer therapeutics 19 (1) (2019)